• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa.

作者信息

Van Woert M H, Mueller P S

出版信息

Clin Pharmacol Ther. 1971 Mar-Apr;12(2):360-7. doi: 10.1002/cpt1971122part2360.

DOI:10.1002/cpt1971122part2360
PMID:5577484
Abstract
摘要

相似文献

1
Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa.左旋多巴治疗帕金森病时的葡萄糖、胰岛素及游离脂肪酸代谢
Clin Pharmacol Ther. 1971 Mar-Apr;12(2):360-7. doi: 10.1002/cpt1971122part2360.
2
Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism.
N Engl J Med. 1972 Oct 12;287(15):729-33. doi: 10.1056/NEJM197210122871501.
3
Abnormal insulin secretion in Parkinson's disease before and during L-dihydroxyphenylalanine (L-dopa) therapy.帕金森病患者在左旋多巴（L - 多巴）治疗前及治疗期间的胰岛素分泌异常。
J Endocrinol. 1973 Dec;59(3):523-34. doi: 10.1677/joe.0.0590523.
4
Glucose kinetics and fatty acids in dogs on matched insulin infusion after glucose load.葡萄糖负荷后接受匹配胰岛素输注的犬类的葡萄糖动力学和脂肪酸情况
Metabolism. 1971 Oct;20(10):954-67. doi: 10.1016/0026-0495(71)90016-3.
5
Effects of long-term L-dopa therapy on carbohydrate metabolism in patients with Parkinson's disease.长期左旋多巴治疗对帕金森病患者碳水化合物代谢的影响。
Eur Neurol. 1976;14(3):229-39. doi: 10.1159/000114744.
6
Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.肝病中胰岛素分泌减少、生长激素水平升高及葡萄糖耐量异常。
J Lab Clin Med. 1969 Jan;73(1):25-33.
7
[Glucose tolerance, insulin secretion, levels of free fatty acids and growth hormone in hepatic cirrhosis].[肝硬化患者的葡萄糖耐量、胰岛素分泌、游离脂肪酸水平及生长激素水平]
Rev Clin Esp. 1974 Feb 28;132(4):299-306.
8
[Aging and pancreatic secretion].[衰老与胰腺分泌]
Horumon To Rinsho. 1969 Oct;17(10):863-9.
9
Sebum-excretion rate and skin-surface lipid composition in Parkinson's disease before and during therapy with levodopa.帕金森病患者在左旋多巴治疗前及治疗期间的皮脂分泌率和皮肤表面脂质成分
Lancet. 1971 Jun 19;1(7712):1271-2. doi: 10.1016/s0140-6736(71)91782-x.
10
Amantadine enhancement of L-DOPA induced growth hormone stimulation.金刚烷胺增强左旋多巴诱导的生长激素刺激作用。
Horm Metab Res. 1973 Nov;5(6):454-6. doi: 10.1055/s-0028-1093906.

引用本文的文献

1
Sitagliptin attenuates L-dopa-induced dyskinesia by regulating mitochondrial proteins and neuronal activity in a 6-OHDA-induced mouse model of Parkinson's disease.在6-羟基多巴胺诱导的帕金森病小鼠模型中，西他列汀通过调节线粒体蛋白和神经元活动减轻左旋多巴诱导的运动障碍。
J Neural Transm (Vienna). 2025 Jun;132(6):827-843. doi: 10.1007/s00702-025-02907-1. Epub 2025 Mar 17.
2
Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention.生酮饮食与酮补充剂：一种治疗干预策略。
Front Nutr. 2022 Nov 15;9:947567. doi: 10.3389/fnut.2022.947567. eCollection 2022.
3
If Not Insulin Resistance so What? - Comparison of Fasting Glycemia in Idiopathic Parkinson's Disease and Atypical Parkinsonism.
若不是胰岛素抵抗，那又如何？——特发性帕金森病与非典型帕金森综合征空腹血糖水平的比较
Diabetes Metab Syndr Obes. 2022 May 9;15:1451-1460. doi: 10.2147/DMSO.S359856. eCollection 2022.
4
Neurodegenerative Disorders: Spotlight on Sphingolipids.神经退行性疾病：鞘脂 spotlight。
Int J Mol Sci. 2021 Nov 5;22(21):11998. doi: 10.3390/ijms222111998.
5
Identification of the Raman Salivary Fingerprint of Parkinson's Disease Through the Spectroscopic- Computational Combinatory Approach.通过光谱-计算组合方法鉴定帕金森病的拉曼唾液指纹图谱。
Front Neurosci. 2021 Oct 26;15:704963. doi: 10.3389/fnins.2021.704963. eCollection 2021.
6
Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.糖尿病与帕金森病：胰岛素与多巴胺之间的危险关联
Neural Regen Res. 2022 Mar;17(3):523-533. doi: 10.4103/1673-5374.320965.
7
Lipid Metabolism is the common pathologic mechanism between Type 2 Diabetes Mellitus and Parkinson's disease.脂代谢是 2 型糖尿病与帕金森病之间的共同病理机制。
Int J Med Sci. 2020 Jul 6;17(12):1723-1732. doi: 10.7150/ijms.46456. eCollection 2020.
8
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.2型糖尿病与帕金森病关系的分析：一项系统综述
Parkinsons Dis. 2019 Nov 23;2019:4951379. doi: 10.1155/2019/4951379. eCollection 2019.
9
Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus.胰高血糖素样肽1受体激动剂对老年糖尿病患者合并症的影响。
Ther Adv Chronic Dis. 2019 Jul 12;10:2040622319862691. doi: 10.1177/2040622319862691. eCollection 2019.
10
Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases.胰高血糖素样肽-1（GLP-1）类似物在阿尔茨海默病和帕金森病中的神经保护作用。
CNS Drugs. 2019 Mar;33(3):209-223. doi: 10.1007/s40263-018-0593-6.